Cargando…
Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
Polymyalgia rheumatica (PMR) and giant-cell arteritis (GCA) with symptoms of PMR share some pathophysiologic features. Interleukin 6 (IL-6) levels are elevated in both groups. We investigated the effect of tocilizumab (TCZ), an IL-6 inhibitor, in both populations and whether there were any differenc...
Autores principales: | Farinango, Michelle, Ansary, Akhil, Dakka, Amulya, Nazir, Zahra, Shamim, Humaira, Jean, Marie, Umair, Muaaz, Muddaloor, Pratyusha, Chavarria, Yeny, Khan, Safeera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435397/ https://www.ncbi.nlm.nih.gov/pubmed/36059312 http://dx.doi.org/10.7759/cureus.27606 |
Ejemplares similares
-
Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969) -
Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021) -
Ill Effects and Complications Associated to Removable Dentures With Improper Use and Poor Oral Hygiene: A Systematic Review
por: Dakka, Amulya, et al.
Publicado: (2022) -
Prospect of Alpha-Synuclein (A-Syn) Isolation From Saliva as a Promising Diagnostic Biomarker Alternative in Parkinson’s Disease (PD): A Systematic Review
por: Muddaloor, Pratyusha, et al.
Publicado: (2022) -
An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022)